Compound 1855
Identifiers
- Canonical SMILES:
Cc1[nH]c(c2CCCC(=O)c12)-c1ccccc1Oc1ccccc1
- IUPAC name:
3-methyl-1-(2-phenoxyphenyl)-4,5,6,7-tetrahydro-2H-isoindol-4-one
- InChi:
InChI=1S/C21H19NO2/c1-14-20-17(11-7-12-18(20)23)21(22-14)16-10-5-6-13-19(16)24-15-8-3-2-4-9-15/h2-6,8-10,13,22H,7,11-12H2,1H3
- InChiKey:
KLYIVVNLQIHWNI-UHFFFAOYSA-N
External links
![]() 71811973 |
![]() CHEMBL4068988 |
87P |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 2 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
Bromodomain / Histone | 6.55 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 317.14 g/mol | |||
HBA | 3 | |||
HBD | 1 | |||
HBA + HBD | 4 | |||
AlogP | 4.63 | |||
TPSA | 42.09 | |||
RB | 3 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 2 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
10.1016/j.bmcl.2017.02.057 | 13 | BRD4 O60885 |
H4 P62805 |
Biochemical assay | Time-Resolved FRET | pKi (inhibition constant, -log10) | 6.36 | |
10.1016/j.bmcl.2017.02.057 | 13 | BRD4 O60885 |
H4 P62805 |
Cellular assay | MX-1 proliferation assay | MX-1 | pEC50 (half maximal effective concentration, -log10) | 5.85 |
10.1016/j.bmcl.2017.02.057 | 13 | BRD4 O60885 |
H4 P62805 |
Cellular assay | Luciferase reporter | H1299 | pEC50 (half maximal effective concentration, -log10) | 6.55 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5116 | N-[(13-CYCLOHEXYL-6,7-DIHYDROINDOLO[1,2-D][1,4]BENZOXAZEPIN-10-YL)CARBONYL]-2-METHYL-L-ALANINE | DB08031 | |
0.4637 | 6-PHENYL[5H]PYRROLO[2,3-B]PYRAZINE | DB07364 | |
0.4492 | Molindone | DB01618 | |
0.4333 | 3-CYCLOHEXYL-1-(2-MORPHOLIN-4-YL-2-OXOETHYL)-2-PHENYL-1H-INDOLE-6-CARBOXYLIC ACID | DB07570 | |
0.4167 | AKI-001 | DB07266 | |
0.4155 | Cilansetron | DB04885 | |
0.4124 | 9-HYDROXY-6-(3-HYDROXYPROPYL)-4-(2-METHOXYPHENYL)PYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE | DB07006 | |
0.4121 | Ondansetron | DB00904 | |
0.4108 | N-[(1R)-3-(4-HYDROXYPHENYL)-1-METHYLPROPYL]-2-(2-PHENYL-1H-INDOL-3-YL)ACETAMIDE | DB07991 | |
0.4072 | CRA_17312 | DB02084 | |
0.4071 | Atorvastatin | DB01076 | |
0.4039 | 2-[2-(2-FLUOROPHENYL)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE | DB07728 | |
0.4031 | Rucaparib | DB12332 | |
0.4024 | 2,3-diphenyl-1H-indole-7-carboxylic acid | DB08709 | |
0.3991 | Pyrroloquinoline Quinone | DB03205 |